Female Sexual Dysfunction: Pharmaceutical Sham or an Opportunity for Empowerment? Meghan Murphy explores this controversial topic with Dr Thea Cacchioni, professor of Sociology and Women’s & Gender Studies. Dr Cacchioni has taught at the University of British Columbia in Vancouver and the Okanagan and recently gave a talk, as part of the Ruth Wynn Woodward Speaker Series at SFU entitled: “Sex, Gender & Pharmaceuticals: The Search for the ‘Pink’ Viagra.” On June 18th, 2010 she will testify at an FDA advisory hearing against the approval of Flibanserin, a drug proposed to treat ‘hypo-active sexual desire disorder’ in pre-menopausal women.
Thank you for reading this story…
More people are reading rabble.ca than ever and unlike many news organizations, we have never put up a paywall – at rabble we’ve always believed in making our reporting and analysis free to all, while striving to make it sustainable as well. Media isn’t free to produce. rabble’s total budget is likely less than what big corporate media spend on photocopying (we kid you not!) and we do not have any major foundation, sponsor or angel investor. Our main supporters are people and organizations -- like you. This is why we need your help. You are what keep us sustainable.
rabble.ca has staked its existence on you. We live or die on community support -- your support! We get hundreds of thousands of visitors and we believe in them. We believe in you. We believe people will put in what they can for the greater good. We call that sustainable.
So what is the easy answer for us? Depend on a community of visitors who care passionately about media that amplifies the voices of people struggling for change and justice. It really is that simple. When the people who visit rabble care enough to contribute a bit then it works for everyone.
And so we’re asking you if you could make a donation, right now, to help us carry forward on our mission. Make a donation today.